BioSpace News Archive

Business

Processa Pharmaceuticals to Host Conference Call to Discuss First Quarter 2022 Results and Provide Drug Development Update on May 12, 2022 at 4:30 p.m. EST

Processa Pharmaceuticals, Inc. announces today it will host a conference call and live webcast on May 12, 2022 at 4:30 p.m. EST to discuss its results for the first quarter and provide an update on its clinical pipeline.

May 5, 2022
·
2 min read
Business

SCYNEXIS to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12

SCYNEXIS, Inc. today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, May 12, 2022 to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2022.

May 5, 2022
·
1 min read
Genetown

Acer Therapeutics to Participate in H.C. Wainwright Global Investment Conference

Acer Therapeutics Inc. announced that Acer’s management team will virtually present at, and participate in, the H.C. Wainwright Global Investment Conference May 24-26, 2022.

May 5, 2022
·
1 min read
Biotech Beach

Tarsus Presents New Findings from Two Studies Demonstrating the Impact of Demodex Blepharitis at the ARVO 2022 Annual Meeting

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), presented data from its Atlas Continuation study on the negative impact Demodex blepharitis has on daily life and visual function among certain patient groups, as well as preliminary findings from the Pandora study on coexisting bacterial burden for patients with Demodex blepharitis.

May 5, 2022
·
5 min read
Business

Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery

Palisade Bio and co-development partner Newsoara Biopharma Co. Ltd, today announced they have received clearance from the National Medical Products Administration (NMPA) in China to proceed with their Phase 3 clinical trial to evaluate LB1148 for accelerated return of bowel function in adult patients undergoing bowel/abdominal surgery.

May 5, 2022
·
6 min read
Business

Coherus BioSciences Appoints Charlie Newton to Board of Directors

Coherus BioSciences, Inc. today announced the appointment of former investment banker and renowned biotech strategist Charlie Newton to its Board of Directors.

May 5, 2022
·
5 min read
Business

Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors

Scopus BioPharma Inc. today announced the appointment of Raphael (“Rafi”) Hofstein, Ph.D. to its Board of Directors (“Board”).

May 5, 2022
·
5 min read
Genetown

Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Biofrontera Inc. announced its sponsorship of the 17th Edition of the Music City Symposium for Cosmetic Advances & Laser Education, being held May 11-15, 2022 in Nashville, Tenn.

May 5, 2022
·
5 min read
Business

Avance Biosciences Announces Validation of New Facilities, Expansion of Mammalian Cell Culture and Protein Analysis Services

Avance Biosciences announced completion of move-in and validation of an additional 26,000 square feet of laboratory space acquired in the past year.

May 5, 2022
·
2 min read
Biotech Bay

Anitoa Introduces Portable RT-PCR Molecular Test for Dengue Virus

Anitoa systems, market leader in portable molecular testing, today announced the availability of an RT-PCR solution for testing dengue virus.

May 5, 2022
·
2 min read